"
Team:Virginia Commonwealth/Literature
From 2009.igem.org
(Difference between revisions)
GMcArthurIV (Talk | contribs) |
GMcArthurIV (Talk | contribs) |
||
| Line 14: | Line 14: | ||
*[http://www.nature.com/nbt/journal/v26/n7/full/nbt1413.html <font color="#000000">'''Refinement and standardization of synthetic biological parts and devices'''</font>] | *[http://www.nature.com/nbt/journal/v26/n7/full/nbt1413.html <font color="#000000">'''Refinement and standardization of synthetic biological parts and devices'''</font>] | ||
*[http://www.jbioleng.org/content/3/1/4 <font color="#000000">'''Measuring the activity of BioBrick promoters using an in vivo reference standard'''</font>] | *[http://www.jbioleng.org/content/3/1/4 <font color="#000000">'''Measuring the activity of BioBrick promoters using an in vivo reference standard'''</font>] | ||
| + | *[http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17251159&ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum <font color="#000000">'''Biology by design: reduction and synthesis of cellular components and behaviour'''</font>] by You ''et al.'' | ||
| + | *[http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRV-4KWTFBB-3&_user=709071&_coverDate=10%2F31%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000039638&_version=1&_urlVersion=0&_userid=709071&md5=55327bdfbda5081b078808963c8a92b6 <font color="#000000">'''Genetic parts to program bacteria'''</font>] by Chris Voigt | ||
| + | *[http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRV-4KPX8RY-1&_user=709071&_coverDate=10%2F31%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000039638&_version=1&_urlVersion=0&_userid=709071&md5=7a316893fbee50cab2742cc3b6de73b4 <font color="#000000">'''Systems biology as a foundation for genome-scale synthetic biology'''</font>] by B. Palsson ''et al.'' | ||
<br /> | <br /> | ||
==Foundations== | ==Foundations== | ||
| Line 20: | Line 23: | ||
*[http://dspace.mit.edu/handle/1721.1/21168 <font color="#000000">'''Idempotent Vector Design for Standard Assembly of Biobricks'''</font>] by Tom Knight | *[http://dspace.mit.edu/handle/1721.1/21168 <font color="#000000">'''Idempotent Vector Design for Standard Assembly of Biobricks'''</font>] by Tom Knight | ||
*[http://www.jbioleng.org/content/2/1/5 <font color="#000000">'''Engineering BioBrick vectors from BioBrick parts'''</font>] by Reshma Shetty ''et al.'' | *[http://www.jbioleng.org/content/2/1/5 <font color="#000000">'''Engineering BioBrick vectors from BioBrick parts'''</font>] by Reshma Shetty ''et al.'' | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
<br /> | <br /> | ||
==Applications== | ==Applications== | ||
Revision as of 13:52, 6 June 2009
Below is a compilation of papers and articles relevant to iGEM, synthetic biology and metabolic pathway engineering.
Introductions
- Adventures in synthetic biology a comic by Drew Endy
- Extreme genetic engineering: an introduction to synthetic biology by the ETC Group
- Engineering life: building a FAB for biology
- The iGEM competition: building with biology by James Brown
Frameworks
- Foundations for engineering biology by Drew Endy
- Toward scalable parts families for predictable design of biological circuits by Julius Lucks et al.
- Refinement and standardization of synthetic biological parts and devices
- Measuring the activity of BioBrick promoters using an in vivo reference standard
- Biology by design: reduction and synthesis of cellular components and behaviour by You et al.
- Genetic parts to program bacteria by Chris Voigt
- Systems biology as a foundation for genome-scale synthetic biology by B. Palsson et al.
Foundations
- A synthetic oscillatory network of transcriptional regulators by Michael B. Elowitz and Stanislas Leibler
- Construction of a genetic toggle switch in Escherichia coli by James J. Collins et al.
- Idempotent Vector Design for Standard Assembly of Biobricks by Tom Knight
- Engineering BioBrick vectors from BioBrick parts by Reshma Shetty et al.
Applications
Artemisinin project
- Production of isoprenoid pharmaceuticals by engineered microbes by Jay Keasling et al.
- Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli by Jay Keasling et al.
Tumor-destroying bacteria project
- Environmentally controlled invasion of cancer cells by engineered bacteria by Chris Voigt et al.
Implications
- DNA synthesis and biological security
- The promise and perils of synthetic biology by J. Tucker and R. Zilinskas
